Apoptosis and cell proliferation in esophageal sqamous cell carcinoma treated by chemotherapy

Cancer Letters

Volumn 158, Issue 2, 2000, Pages 211-216

  Okumura, Hiroshi ^a   Natsugoe, Shoji ^a   Nakashima, Saburou ^a   Matsumoto, Masataka ^a   Sakita, Hironori ^a   Nakano, Shizuo ^a   Kusano, Chikara ^a   Baba, Masamichi ^a   Takao, Sonshin ^a   Furukawa, Tatsuhiko ^a   Akiyama, Shin Ichi ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Chemotherapy; Esophageal squamous cell carcinoma; p53; Proliferation

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL DIVISION; DRUG EFFECT; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NICK END LABELING; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034297507     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00526-7     Document Type: Article

References (20)

1. M. Baba, T. Aikou, H. Yoshinaka, S. Natsugoe, T. Fukumoto, H. Shimazu, K. Akazawa, Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus, Ann. Surg. 219 (1994) 310-316.
2. L.P. Elisabeth, L.E. Pierre, M. Bernard, M. Guy, B.H. Mohamed, G. Daniel, B. Dominique, P.C. Jean, L. Bernard, A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus, Cancer 73 (1994) 1779-1784.
3. A.A. Forastiere, Treatment of locoregional esophageal cancer, Semin. Oncol. 19 (1992) 57-63.
4. D.P. Kelsen, R. Ginsberg, T.F. Pajak, D.G. Sheahan, L. Gunderson, J. Mortimer, N. Estes, D.G. Haller, J. Ajani, W. Kocha, B.D. Minsky, J.A. Roth, Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer, N. Engl. J. Med. 339 (1998) 1979-1984.
5. R.W. Carey, A.D. Hilgenberg, E.W. Wilkins Jr., N.C. Choi, D.J. Mathisen, H.C. Grillo, J.C. Wain, D.L. Logan, C. Bromberg, Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus, Cancer Invest. 11 (1993) 99-105.
6. C.B. Thompson, Apoptosis in the pathogenesis and treatment of disease, Science 267 (1995) 1456-1462.
7. A.H. Wyllie, Apoptosis, Br. J. Cancer 67 (1993) 205-208.
8. S.W. Lowe, S. Bodis, A. McClatchey, L. Remington, H.E. Ruley, D.E. Fisher, D.E. Housman, T. Jacks, p53 status and the efficacy of cancer therapy in vivo, Science 266 (1994) 807-810.
9. M.B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, R.W. Craig, Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 51 (1991) 6304-6311.
10. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, D. Beach, p21 is a universal inhibitor of cyclin kinases, Nature 366 (1993) 701-704.
11. J.H. Wijsman, R.R. Jonker, R. Keijzer, C.J. van de Velde, C.J. Cornelisse, J.H. van Dierendonck, A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA, J. Histochem. Cytochem. 41 (1993) 7-12.
12. B. Ansari, P.J. Coates, B.D. Greenstein, P.A. Hall, In situ endlabeling detects DNA strand breaks in apoptosis and other physiological and pathological states, J. Pathol. 170 (1993) 1-8.
13. J. Gerdes, L. Li, C. Schlueter, M. Duchrow, C. Wohlenberg, C. Gerlach, I. Stahmer, S. Kloth, E. Brandt, H.D. Flad, Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67, Am. J. Pathol. 138 (1991) 867-873.
14. M. Ikeguchi, H. Saito, K. Katano, S. Tsujitani, M. Maeta, N. Kaibara, Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma, Oncology 54 (1997) 311-317.
15. P. Hermanek, L.H. Sobin, UICC TOM Classification of Malignant Tumors, 4th Edition, 2nd Revision, Spring-Verlag, Berlin, 1992.
16. Japanese Society for Esophageal Disease, Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Eesophagus, 8th Edition, 1992.
17. C. Lu, N. Tanigawa, Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma, Cancer Res. 57 (1997) 221-224.
18. T. Wagata, I. Shibagaki, M. Imamura, Y. Shimada, J. Toguchida, D.W. Yandell, M. Ikenaga, T. Tobe, K. Ishizaki, Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas, Cancer Res. 53 (1993) 846-850.
19. M. Sarbia, M. Stahl, U. Fink, R. Willers, S. Seeber, H.E. Gabbert, Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities, Clin. Cancer Res. 4 (1998) 2991-2997.
20. L.D. Wang, Q. Zhou, W.C. Yang, C.S. Yang, Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions: study of a high-risk population in northern China, Anticancer Res. 19 (1999) 369-374.